A B S T R A CT Experiments were performed to evaluate the role of prostaglandin synthesis in the regulation of coronary blood flow in dog hearts. The left main coronary artery was cannulated and flow measured both in otherwise intact animals and in canine heart-lung preparations. Prostaglandin E was measured by radioimmunoassay. Reactive hyperemia (flow after occlusion release) was induced by coronary occlusion for 10, 15, and 20 s and was 39±13 (mean±SEM), 66+21, and 82±24 ml, respectively. Indomethacin, an inhibitor of prostaglandin synthetase, reduced reactive hyperemia at 10, 15, and 20 s to 15-+-5, 33+11, and 47+17 ml, respectively (P <0.05). Meclofenamate, a different prostaglandin synthetase inhibitor, gave similar results. In a second group of five dogs, prostaglandin production of the heart was examined in response to 20-s occlusions.
INTRODUCTION
Prostaglandins are a group of ubiquitous vasoactive lipids which have been postulated to have an important regulatory role in the cardiovascular system (1) Received for publication 23 Augutst 1974 and in revised form 13 January 1975. capacity of the canine heart to both synthesize and metabolize prostaglandins has been demonstrated (2) . The recent observation that the adenine nucleotides ATP and ADP are potent releasers of a prostaglandinlike material from the rabbit heart (3) and earlier evidence that the adenine nucleoside adenosine may be an important mediator of coronary vascular resistance (4) suggest that prostaglandins and the adenine nucleotides and their derivatives may interact in the regulation of coronary blood flow. There is, in fact, some evidence to suggest that adenosine is not the sole mediator of the altered coronary blood flow in reactive hyperemia and hypoxia (5, 6) . Therefore, experiments were designed to elucidate the role of endogenous prostaglandin synthesis in the regulation of coronary blood flow.
METHODS

Intact animals
Mongrel dogs of either sex were anesthetized with sodium pentobarbital, 30 mg/kg i.v. A transverse thoracotomy was made in the fourth intercostal space with the animals on positive pressure respiration. 100 U/kg heparin was administered initially and then 10 U/kg per h. A stainless steel Gregg cannula was inserted into the left subclavian artery, which had previousy been ligated distally. The cannula was passed across the aortic arch and into the left main coronary artery, where it was tied in place by a 4-0 silk suture passed around the artery during earlier dissection. This cannula was perfused with blood obtained from the femoral artery. The perfusion circuit consisted of A-in tubing and an electromagnetic flow probe (Carolina Medical Electronics, Inc., King, N. C.). All flow meters were calibrated by passing canine blood through them with a constant flow pump and timing the collection of blood. A cannula was then placed into the coronary sinus. first intercostal artery, the left subclavian artery, the brachiocephalic artery, and superior and inferior vena cavae, and ligation of the azygous vein. Heparin, 100 U/kg, was administered intravenously and the brachiocephalic artery was cannulated with an 18 F aortic cannula. A wxide-bore cannula was inserted into the right atrium through the atrial appendage. The aortic and right atrial cannulas were connected to the perfusion circuit as shown in Fig. 1 . The blood was directed through tubing ('1 in ID) from the aortic cannula to the "systemic" and coronary perfusion circuits. The systemic circuit consisted of an electromagnetic flowmeter, a plastic 1-liter reservoir placed 137 cm above the animal's heart, a heat exchanger maintained at 370C by a circulating water bath, a bubble trap, and a resistance clamp. The input gas to the respirator was changed from room air to 21% 02, 5% C02, and 74%/c 'N2, obtained from a gas-mixing system (8) . The aorta was occluded proximal to the first intercostal artery. The systemic flow was maintained at 1 liter/mim by adjusting the resistance clamp. The circulation of the heart and lungs was completely isolated from the remainder of the animal. Once systemic perfusion was instituted, the left main coronary artery and coronary sinus were cannulated as described above. Mean aortic pressure (and thereby coronary perfusion pressure) was maintained at 85-92 mm Hg by the arterial reservoir.
Prostaglandin measurements
Blood was withdrawn into heparinized glass tubes and centrifuged at 4°C. 3 ml plasma were added to glass extraction tubes, in which 600 cpim of chromatographically pure [1H] prostaglandin El (New England Nuclear, Boston, Mass.), in ethyl alcohol had previously been dried under nitrogen. The plasma was mixed to ensure that the labeled prostaglandin was in solution, acidified to pH 3.5 with formic acid, and extracted twice with 5 ml of ethyl acetate. The ethyl acetate was evaporated to dryness with N2. The extract was then chromatographed on silicic acid (SilicAR cc 4, 200-325 mesh, Mallinkrodt Chemical Works, St. Louis, Mo.), activated by heating overnight at 1000C. 0.5 g silicic acid in a solution of benzene: ethyl acetate, 60: 40 (solution I) was applied to a glass chromatography column plugged with glass wool. The column was allowed to run dry and then washed with 5 ml of benzene: ethyl acetate: methanol, 60: 40: 2. The extract was dissolved in 0.2 ml of benzene: ethyl acetate: methanol 60: 40: 10. Next 0.6 ml of solution I was added to the extract and mixed and then the mixture was applied to the column. The extraction tube was then rinsed with 0.2 ml of solution I and this was added to the column. The column ran dry and then was eluted with 1 ml of benzene and subsequently with 0.3 ml of solution I. Prostaglandin A fraction was then eluted with 5.0 ml of solution I, and prostaglandin E was eluted with 11 ml of benzene: ethyl acetate: methanol, 60: 40: 3. The prostaglandin E fraction was evaporated under a N2 stream. This chromatography system provided effective group separation of the prostaglandins, as previously reported in the similar systems (9, 10) . All organic solvents were spectral grade (Fisher Scientific Co., Pittsburgh, Pa.).
The prostaglandin E was converted to prostaglandin B by modifications of a previously published procedure (11 A standard curve from 2 to 0.08 ng prostaglandin B2 was run with each assay. The radioimmunoassay was performed in a Tris buffer system (0.01 M Tris, 1.6 X 10'4 M Ca++, 1.7 X 10' NI NMg++, 0.14 NI NaCl, and 0.1 mg/100 ml gelatin) at pH 7.4. The volume was 0.5 ml. 1 ml of the Tris buffer was added to the tubes containing the converted prostaglandin E fraction and mixed for 1 min. 0.1 and 0.2 ml portions were then added to assay tubes and 0.3 ml was covery of prostaglandin E2 added to plasma and carried through the extraction and assay procedure was 104+19.8%c (SD) over the range from 0.8 to 5.6 ng. Fig. 2 this instrument provided an analog signal proportional to the difference of A-V 02 content and was recorded.
The A-V 02 difference was also continuously multiplied times the coronary blood flow (Q..) by a four-quadrant an.lcg multiplier (Intronics, Newvton, Mass.) to provide a continuous conline sign.l propl-rtion-il to the MV02.
Blood gas analysis
Arterial pH cand percentage of saturation were determined initially and at intervals thrGughA t. e experiment. Arterial pH was mainto.inod between 7.35 and 7.45. Arterial saturation was maintained above 95%.
Myocardial lactate metabolism
Lactate moasurements were performed on blood simultaneously wit' drawn from the cor-nary arterial perfusion circuit and coronary sinus. The A-V lactate concentration times the coronary flEwv waxs taken as t'he lactate consumption or productien of tihe heart. Lactate concentration was determined by the enzymatic reduction of NAD (rapid lactate, Calbiochem, San Diego, Calif.). 5 6 Experimental protocol
Rcactive hApercmia. Reactive hyperemia was induced in five intact animals and six heart-lung preparations by occluding the left main coronary arterial perfusion circuit for 10, 15, and 20-s intervals. In some cases an additional 5-s interval of occlusion was used. 5 min was allowed for recovery between each occlusion, since we found that during this time basal Q, stabilized and the amount of reactive hyperemia was reproducible after this 5-min period. Reactive hyperemia was defined as integral of the flow above basal flow, which occurred during the release of coronary occlusion. This value was obtained by electronically integrating Q, after balancing the integrator (zero conditions) for basal flow conditions; i.e., zero integrator output for basal coronary flow. Also, the Q, signal was conditioned by a half-wave rectifier so that only positive flow conditions would be integrated, since the fall to zero flow during occlusion would be spuriously integrated as a negative flow. Thus, the integrator output was the integral of the flow curve above base-line flow that occurred after occlusion. Prostaglandin synthetase was inhibited by infusing the nonsteroidal anti-inflammatory agents indomethacin or meclofenamate. These chemically different agents have been shown to be potent inhibitors of prostaglandin synthetase in all tissues in which they have been tested (13) , and were specifically shown to reduce canine coronary sinus immunoreactive prostaglandin E concentrations in preliminary experiments. Either compound was dissolved in 0.1 M sodium phosphate buffer (pH 7.4) at a concentration of 1 mg/ml and administered immediately. The indomethacin frequently required mild heating to enhance solubility. That indomethacin and meclofenamate were stable and maintained their pharmacologic activity under these conditions was manifested in their ability to decrease immunoreactive prostaglandin E concentrations. In the intact dogs either indomethacin or meclofenamate (50 mg) was infused into the coronary perfusion circuit at a rate of 2 mg/min. Since indomethacin is rapidly cleared in the dog (to in dog plasma of about 10-20 min) by the liver and to a lesser extent the kidney (14) , intracoronary infusion of the drugs was chosen because prostaglandin synthetase inhibition has been shown to be time-dependent in some tissues (15) . In Reactive hypcrcmiia anid prostaglandidb produictioni. In an additional five heart-lung preparations, prostaglandin production was measured by simultaneously sampling arterial and coronary sinus blood for prostaglandin determinations in the basal state and during reactive hyperemia. Three separate 20-s occlusions were performed at 5-min intervals. The arterial and coronary sinus blood was withdrawn for 30 s immediately after the release of the occlusion. Thus, prostaglandin output by the heart, during this period, was calculated as the coronary sinus prostaglandin concentrations minus the arterial concentration times the average flow during the 30-s period (obtained by integration). Indomethacin (7 mg) was then administered to the perfusion circuit (resultant concentration approximately 3.5 ug/rml) and 30 min later the procedures were repeated.
Statistics
The data were analyzed by a paired t test (16 It PG output, calculated as [PG] difference of blood collected during the 30 s after the occlusion release X average flow during the same time period. ¶ 7 mg indomethacin administered to entire circuit, the volume of which was 2 liters (approximately 3.5 ug/ml).
the slopes of the lines describing the relationship between reactive hyperemia and the duration of occlusion after indomethacin and meclofenamnate are not statistically significant (P > 0.1).
The original tracings of physiologic data obtained from a heart-lung preparation are shown in Fig. 5 . Reactive hyperemia after a 20-s occlusion of the coronary perfusion circuit was decreased after indomethacin (7 mg). Systemic arterial pressure, left atrial pressure, systemic flow, heart rate, and basal coronary blood flow were unaffected by indomethacin but reactive hyperemia was significantly reduced after indomethacin.
Reactive hyperemia was repeatedly induced in two heart-lung preparations and one intact animal over 150 min without any pharmacologic interventions, and was found to be stable and reproducible.
Prostaglandin production. In five heart-lung preparations, prostaglandin production by the heart averaged 18.6±4.9 ng/min in the basal state. Blood collected in the 30 s immediately after the release of a 20-s occlusion demonstrated a significant rise in the production of prostaglandin E-like material to 35.3±5.6 ng/min (P < 0.025). The cardiac production of prostaglandin E-like material in nanograms per minute was calculated from the concentration difference (coronary sinus minus arterial in nanograms per milliliter) times the coronary flow (milliliters per minute). Basal cardiac production was calculated from the basal coronary flow times the concentration difference in the basal state. For the prostaglandin output during reactive hyperemia, arterial and coronary sinus blood were collected for 30 s immediately after occlusion release. The product of the average coronary flow during the 30-s collection period and the concentration difference during the collection period was determined. In the basal state there was no significant reduction of coronary flow 30 min after 7 mg of indomethacin. After indomethacin the difference in prostaglandin concentration across the coronary bed fell in each preparation and the average A-V difference decreased from 0.16±0.04 to 0.07±0.01 ng/ml. Also, after indomethacin, prostaglandin production fell in each animal and the average decreased from 18.7±4.8 to 7.2+ 1.4 ng/min. However, neither of these values reached statistical significance (Table I ). It should be noted that basal prostaglandin concentrations were determined from samples drawn 30 min after indomethacin administration. During the next 20 min, each of the five preparations had further decrease in the concentration of coronary sinus immunoreactive prostaglandin E, to levels approaching arterial levels. After indomethacin there was no significant increase in prostaglandin output in response to the 20-s coronary artery occlusion (basal 7.2±1.4 ng/min, during reactive hyperemia 7.2±2 ng/ min) and both the peak flow and total amount of reactive hyperemia were significantly reduced (Table I) .
Response to adenosine
To determine if indomethacin had a nonspecific de- pressant effect on coronary vascular reactivity in general and to the vasodilator response to adenosine in specific, adenosine was injected into the coronary perfusion circuit both before and after these drugs were administered. There were no significant effects on the adenosine dose-response curve in three heart-lung preparations after indomethacin. Fig. 6 represents the response curve of the three preparations before and after indomethacin.
Lactate metabolism
In five of the heart-lung preparations. to determine if prostaglandin synthetase blockade interfered with aerobic metabolism, left ventricular lactate consumption was measured by simultaneously determining lactate concentrations in the arterial and coronary sinus blood and the left main coronary flow. In two of the preparations lactate consumption was determined before and after indomethacin, in two preparations before and after meclofenamate, and in one preparation no drug was given. In all preparations there was a slight time-dependent increase in lactate extraction, which did not exceed 18% in any preparation. Lactate extraction averaged 9.8±0.8 mg/min during the control period and 1 h after administration of drugs in four preparations was 11.0±1 mg/min.
In the five heart-lung preparations and two intact dogs in wlhich oxygen consumption was measured, there was no change in OIN-02 during the experimental procedures. WMN 02 averaged 13±2.5 ml/min before prostaglandin synthetase inhibition and 12.5±3.0 ml/mi after inhibition.
DISCUSSION
These data suggest that prostaglandin synthesis is necessary for the normal modulation of blood flow in response to brief periods of ischemia in the canine heart.
Although coronary blood flow is related to the metabolic requirements of the heart (17, 18) , not all of the factors involved in regulating coronary blood flow are known (18) . The flow debt incurred during brief occlusion of a coronary artery is repaid up to two-fold and the coronary A-Vo2 difference actually decreases while flow is still increased during the later stages of reactive hyrperemia. thus leading to the overpayment of the calculated 02 debt in occlusions of 15 s or longer (19) . Trhese findings suggest that other factors in addition to cardiac metabolic products are involved in the regulation of coronary blood flow.
Endogenous prostaglandin synthesis is thought to be of possible importance in the regulation of blood flow in the kidney (20) , lung (21) . skin (22) . and possibly other organs. Relatively little is known about the physiologic role of prostaglandins in the heart. Prostaglandin svnthetase activity has been demonstrated in canine heart as has prostaglandin dehydrogenase, an important enzyme in prostaglandin metabolism (2) . Furthermore, prostaglandin receptors are present in the canine heart' since infused prostaglandin E results in an increase in coronarv blood flow and in contractility (23) .
A possible role for prostaglandins in the regulation of coronary blood flow has been suggested recently. Prolonged occlusion (10 mmil) of a coronary artery in the isolated perfused rabbit heart results in the release of prostaglandin-like material about 50% of the time in an amount measurable by bioassay (3' ). In addition, the adenine nucleotides ATPI and ADP, but not adenosine, were consistent releasers of prostaglandin E-like material. These findings suggest a possible interrelationship between mvocardial metabolism and purine nucleotides, on the one hand, and prostaglandin synthesis and release. on the other.
The present data clearly demonstrate that the nonsteroidal anti-inflammatory agents indomethacin and meclofenamate result in a diminution of reactive hyperemia, associated with a decrease in cardiac immunoreactive prostaglandin E production. Although there are difficulties associated with the radioinmnmunoassay of prostaglandin E, as recently discussed (10) First, indomethacin at a concentration of 10' MI has been shown to hav-e no effect on calcium uptake by guinea pig aortic microsomes (24) . Furthermore, indomethacin (5.6 X 10-1\M) has no significant effect on calcium uptake by the electrically stimulated guinea pig aorta (25) . Finally. indonmethacin (5 X 10' M) has no effect on the calcium, sodium, or potassium fluxes of guinea pig heart muscle (26) . The alpparent concentration of indomethacin in the heart-lung preparation in the present studies was either 2.8 X 10' M or 1.1 X 10' M but the effective concentration may have been considerably lower, since over 90% of indomethacin in canine plasma is protein bound (27 (5, 29) . Although it has not been proved, it has been speculated that the inhibition of the adenosine response is a result of the phosphodiesterase inhibition by the nmethylxanthines (30) . Thus, the failure of indomiethacin to inhibit the adenosine response in the present studies provides further evidence that indomethacin is not exerting its effect on reactive hyperemia through phosphodiesterase inhibition.
Although prostaglandins of the E series are potent vasodilators and are continuously produced by the heart in the dog heart-lung preparation, the failure of prostaglandin synthetase inhibition to consistently decrease basal coronary blood flow suggests that continuous prostaglandin production is not necessary for the maintenance of basal flow. This view is consistent with the conclusions of a recently published report (31) . On the other hand, the consistent increase in prostaglandin production during reactive hyperemia suggests that prostaglandin might be involved in modulating this response. The consistent decrease in postocclusive reactive hyperemia after prostaglandin synthetase inhibition supports this conclusion. A preliminary report has been published that also suggests that prostaglandins are released from the dog heart during reactive hyperemia (32) . Another laboratory (33) , however, has failed to demonstrate any effect of indomethacin on reactive hyperemia. These investigators examined only peak-flow hyperemic responses. In the present study, whereas peak-flow responses after 20-s occlusions were significantly reduced by indomethacin, peak-flow responses after shorter occlusions were not significantly reduced. However, indomethacin and meclofenamate significantly reduced integrated flow after occlusion release for occlusions of all durations (Figs. 3 and 4) . That reactive hyperemia is not abolished after prostaglandin synthetase inhibition suggests that factors in addition to prostaglandin E are involved in modulating this response.
The possibility that prostaglandin E modulates coronary vascular response to hypoxia or to myocardial infarction awaits further investigation. Similarly, the precise relationship between prostaglandin E and other putative determinants of coronary blood flow, such as adenosine, remains to be elucidated.
